GPT and metabolic dysfunction-associated steatohepatitis: Injection of doses 1 and 2 (dose 1: 5 × 109 EVs per mouse per injection; dose 2: 2.5 × 109 EVs per mouse per injection) of EVs induced a significant reduction of alanine aminotransferase (ALT) in the plasma of NASH mice (Figure 2B).